Tag Archives: MMSI

Top Casino Stocks To Invest In Right Now

&l;p&g;&l;img class=&q;size-large wp-image-8068&q; src=&q;http://blogs-images.forbes.com/bensin/files/2018/08/xuke-1200×799.jpg?width=960&q; alt=&q;&q; data-height=&q;799&q; data-width=&q;1200&q;&g; Xu Ke speaking at a tech conference in Beijing.

Beijing native&a;nbsp;Xu Ke is really good with numbers. As an exchange student at the University of Riverside, California, in 2013, she developed a knack for poker, and though she was not yet 21 (the general minimum gambling age in the U.S.)&a;nbsp;at the time, the existence of&a;nbsp;online poker and lenient Southern California casino laws allowed her to play regularly and hone her&a;nbsp;skills in probability and risk assessment.

Her days in card rooms both digital and physical allowed her to meet plenty of interesting, unconventional characters, including investors in cryptocurrency, back before digital currencies hit the mainstream. She was intrigued and began&a;nbsp;mining Bitcoin. The deeper she dug into Bitcoin, the more she agreed with its philosophy of decentralization via blockchain.

Top Casino Stocks To Invest In Right Now: Empire Resorts Inc.(NYNY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Wendys (NASDAQ: WEN) and Empire Resorts (NASDAQ:NYNY) are both retail/wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Top Casino Stocks To Invest In Right Now: Capricor Therapeutics, Inc.(CAPR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media headlines about Capricor Therapeutics (NASDAQ:CAPR) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Capricor Therapeutics earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media stories about the biotechnology company an impact score of 46.8406921113539 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Top Casino Stocks To Invest In Right Now: Financial Institutions Inc.(FISI)

Advisors’ Opinion:

  • [By Max Byerly]

    Peoples Bancorp (NASDAQ:PEBO) and Financial Institutions (NASDAQ:FISI) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.

  • [By Joseph Griffin]

    Financial Institutions, Inc. (NASDAQ:FISI) – Piper Jaffray Companies upped their Q1 2019 earnings per share (EPS) estimates for Financial Institutions in a research report issued on Monday, February 4th. Piper Jaffray Companies analyst M. Breese now expects that the bank will earn $0.61 per share for the quarter, up from their previous forecast of $0.60. Piper Jaffray Companies also issued estimates for Financial Institutions’ Q2 2019 earnings at $0.62 EPS, Q3 2019 earnings at $0.69 EPS, Q4 2019 earnings at $0.70 EPS, FY2019 earnings at $2.62 EPS and Q3 2020 earnings at $0.76 EPS.

  • [By Motley Fool Transcribers]

    Financial Institutions Inc  (NASDAQ:FISI)Q4 2018 Earnings Conference CallFeb. 01, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Financial Institutions (FISI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Casino Stocks To Invest In Right Now: Forest City Realty Trust, Inc.(FCE.A)

Advisors’ Opinion:

  • [By Max Byerly]

    Piedmont Office Realty Trust (NYSE: FCE.A) and Forest City Realty Trust (NYSE:FCE.A) are both mid-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Top Casino Stocks To Invest In Right Now: Merit Medical Systems Inc.(MMSI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribing]

    Merit Medical Systems (NASDAQ:MMSI) Q2 2018 Earnings Conference CallJul. 23, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

  • [By Max Byerly]

    Merit Medical Systems, Inc. (NASDAQ:MMSI) has been assigned a consensus recommendation of “Buy” from the fourteen brokerages that are presently covering the company, Marketbeat.com reports. Thirteen research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $52.00.

  • [By Ethan Ryder]

    BNP Paribas Arbitrage SA lessened its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 54.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,272 shares of the medical instruments supplier’s stock after selling 8,717 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Merit Medical Systems were worth $372,000 at the end of the most recent reporting period.

Top Casino Stocks To Invest In Right Now: Powell Industries Inc.(POWL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    US Bancorp DE lifted its stake in shares of Powell Industries, Inc. (NASDAQ:POWL) by 16.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,842 shares of the industrial products company’s stock after buying an additional 1,908 shares during the quarter. US Bancorp DE owned about 0.12% of Powell Industries worth $371,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Media headlines about Powell Industries (NASDAQ:POWL) have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Powell Industries earned a daily sentiment score of 0.10 on Accern’s scale. Accern also gave media coverage about the industrial products company an impact score of 47.4917283321983 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Best Blue Chip Stocks To Invest In Right Now

Dividend growth investing can be a great way to boost your passive income over time. To do it right, though, you have to find stocks that can both grow their dividends faster than inflation and have sustainable free cash flows for the long haul.

Gilead Sciences (NASDAQ:GILD), a blue chip biotech stock, meets both of these critical criteria. Even so, this top biotech is rarely considered purely for its prospects as a dividend growth stock. The reason? Gilead only started doling out a dividend approximately three years ago this month. As a result, the company has yet to shed its well-earned image as a top growth stock within the broader investing community.

Image Source: Getty Images.

However, I think this underappreciated dividend growth play is worth adding to your portfolio right now. Here’s why.

Gilead’s risks are overstated

There are two big knocks against Gilead as a dividend growth stock. First off, the company’s hepatitis C franchise has literally imploded since hitting a high watermark in late 2015. Gilead has thus had to rely on its core HIV franchise to pick up the slack, and that strategy has so far failed to keep the company’s top line moving in the right direction. Despite several new product launches in HIV, the biotech’s top line remains on track to drop by a disastrous 20.3% this year.

Best Blue Chip Stocks To Invest In Right Now: New York & Company Inc.(NWY)

Advisors’ Opinion:

  • [By Max Byerly]

    Cache (OTCMKTS: CACH) and New York & Company, Inc. (NYSE:NWY) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

  • [By Logan Wallace]

    New York & Company (NYSE:NWY) will announce its earnings results after the market closes on Thursday, May 24th.

    New York & Company (NYSE:NWY) last issued its quarterly earnings results on Thursday, March 22nd. The specialty retailer reported $0.08 EPS for the quarter. New York & Company had a return on equity of 7.97% and a net margin of 0.61%. The company had revenue of $278.71 million for the quarter. During the same period in the prior year, the firm earned ($0.06) earnings per share.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on New York & Company (NWY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Blue Chip Stocks To Invest In Right Now: CNB Financial Corporation(CCNE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    BidaskClub upgraded shares of CNB Financial (NASDAQ:CCNE) from a hold rating to a buy rating in a research note released on Thursday morning.

    A number of other research analysts have also recently issued reports on CCNE. ValuEngine cut shares of CNB Financial from a strong-buy rating to a buy rating in a report on Wednesday, May 2nd. Zacks Investment Research raised shares of CNB Financial from a sell rating to a hold rating in a report on Thursday, June 14th. Boenning Scattergood reaffirmed a buy rating on shares of CNB Financial in a report on Tuesday, April 17th. Finally, Keefe, Bruyette & Woods assumed coverage on shares of CNB Financial in a report on Tuesday, April 10th. They issued a market perform rating and a $35.00 price target for the company. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Buy and an average price target of $31.50.

  • [By Max Byerly]

    BidaskClub upgraded shares of CNB Financial (NASDAQ:CCNE) from a hold rating to a buy rating in a research note released on Wednesday morning.

    Several other equities research analysts have also issued reports on CCNE. Boenning Scattergood reissued a buy rating and set a $29.50 price target on shares of CNB Financial in a research report on Monday, February 5th. Zacks Investment Research lowered CNB Financial from a buy rating to a sell rating in a research report on Tuesday, February 20th. ValuEngine raised CNB Financial from a buy rating to a strong-buy rating in a research report on Monday, April 2nd. Finally, Keefe, Bruyette & Woods initiated coverage on CNB Financial in a research report on Tuesday, April 10th. They set a market perform rating and a $35.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $31.50.

  • [By Stephan Byrd]

    ILLEGAL ACTIVITY WARNING: “CNB Financial (CCNE) Rating Lowered to Sell at Zacks Investment Research” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at www.tickerreport.com/banking-finance/3370450/cnb-financial-ccne-rating-lowered-to-sell-at-zacks-investment-research.html.

Best Blue Chip Stocks To Invest In Right Now: Merit Medical Systems Inc.(MMSI)

Advisors’ Opinion:

  • [By Max Byerly]

    Eagle Boston Investment Management Inc. increased its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 412,344 shares of the medical instruments supplier’s stock after buying an additional 20,334 shares during the quarter. Merit Medical Systems comprises approximately 1.9% of Eagle Boston Investment Management Inc.’s holdings, making the stock its 4th largest position. Eagle Boston Investment Management Inc. owned 0.82% of Merit Medical Systems worth $18,699,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Merit Medical Systems, Inc. (NASDAQ:MMSI) has been assigned a consensus recommendation of “Buy” from the fourteen brokerages that are presently covering the company, Marketbeat.com reports. Thirteen research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $52.00.

Best Blue Chip Stocks To Invest In Right Now: LivePerson Inc.(LPSN)

Advisors’ Opinion:

  • [By Shane Hupp]

    LivePerson (NASDAQ:LPSN) updated its FY18 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $0.11-0.15 for the period, compared to the Thomson Reuters consensus estimate of $0.09. The company issued revenue guidance of $239-243 million, compared to the consensus revenue estimate of $239.45 million.LivePerson also updated its Q2 guidance to $0.00-0.01 EPS.

  • [By Logan Wallace]

    LivePerson, Inc. (NASDAQ:LPSN) SVP Daryl Carlough sold 425 shares of the company’s stock in a transaction dated Wednesday, June 20th. The shares were sold at an average price of $23.80, for a total value of $10,115.00. Following the completion of the sale, the senior vice president now directly owns 14,647 shares of the company’s stock, valued at $348,598.60. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

  • [By Joseph Griffin]

    LivePerson (NASDAQ:LPSN) released its quarterly earnings results on Thursday. The technology company reported $0.01 EPS for the quarter, Bloomberg Earnings reports. LivePerson had a negative return on equity of 2.93% and a negative net margin of 6.95%. The company had revenue of $58.24 million for the quarter, compared to analysts’ expectations of $57.22 million. During the same period in the prior year, the firm earned $0.01 earnings per share. The firm’s revenue was up 14.4% compared to the same quarter last year. LivePerson updated its Q2 guidance to $0.00-0.01 EPS and its FY18 guidance to $0.11-0.15 EPS.

  • [By Rick Munarriz]

    Double-digit growth is back at LivePerson (NASDAQ:LPSN). The provider of high-tech customer support reported fresh financials after Thursday’s market close, delivering its best period of year-over-year revenue growth in nearly three years.

  • [By Timothy Green]

    Shares of LivePerson Inc. (NASDAQ:LPSN) jumped on Friday following the cloud-based chat software company’s first-quarter report. LivePerson beat out analyst estimates across the board, registering its best revenue growth in years. The stock was up about 9.6% at 3:45 p.m. EDT Friday.

Best Blue Chip Stocks To Invest In Right Now: Liquidity Services Inc.(LQDT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Liquidity Services (NASDAQ:LQDT) last issued its quarterly earnings data on Thursday, May 3rd. The business services provider reported ($0.12) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.02. Liquidity Services had a negative net margin of 12.72% and a negative return on equity of 19.31%. The company had revenue of $43.10 million during the quarter, compared to the consensus estimate of $60.16 million. equities analysts forecast that Liquidity Services, Inc. will post -0.71 earnings per share for the current year.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Liquidity Services (LQDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Press coverage about Liquidity Services (NASDAQ:LQDT) has been trending somewhat positive recently, according to Accern. The research group rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Liquidity Services earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned news coverage about the business services provider an impact score of 46.5172522637305 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Best Blue Chip Stocks To Invest In Right Now: CNA Financial Corporation(CNA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Prudential Financial Inc. grew its stake in CNA Financial (NYSE:CNA) by 70.8% during the 1st quarter, HoldingsChannel reports. The firm owned 331,811 shares of the insurance provider’s stock after buying an additional 137,500 shares during the quarter. Prudential Financial Inc.’s holdings in CNA Financial were worth $16,375,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Logan Wallace]

    Cna Financial (NYSE: CNA) and Atlas Financial (NASDAQ:AFH) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, analyst recommendations, profitability, institutional ownership and valuation.

  • [By Joseph Griffin]

    JPMorgan Chase restated their neutral rating on shares of Centrica (LON:CNA) in a research report released on Tuesday.

    Several other equities research analysts have also recently weighed in on CNA. Credit Suisse Group reiterated an outperform rating on shares of Centrica in a research report on Friday, May 4th. Kepler Capital Markets decreased their price objective on shares of Centrica from GBX 190 ($2.58) to GBX 160 ($2.17) and set a buy rating for the company in a research report on Wednesday, February 28th. Royal Bank of Canada raised shares of Centrica to an outperform rating and increased their target price for the stock from GBX 150 ($2.03) to GBX 175 ($2.37) in a research note on Monday, February 26th. HSBC lowered shares of Centrica to a reduce rating and cut their target price for the stock from GBX 150 ($2.03) to GBX 120 ($1.63) in a research note on Wednesday, April 11th. Finally, Deutsche Bank reissued a sell rating and set a GBX 125 ($1.70) target price on shares of Centrica in a research note on Wednesday, January 31st. Five research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company presently has an average rating of Hold and an average price target of GBX 174.63 ($2.37).

Top 10 Stocks For 2019

Overall, stocks did well on Monday, and the Dow climbed 90 points even as other major benchmarks posted similar or slightly larger percentage gains. Market participants seemed to be heartened by President Trump’s performance on the first overseas visit of his administration over the weekend, and most investors were content to wait for clearer gauges of whether the U.S. economy is still as healthy as it has been in recent years.

Yet some stocks didn’t participate in the rally, instead contending with negative news of their own. Zoe’s Kitchen (NYSE:ZOES), GOL Lineas Aereas Inteligentes (NYSE:GOL), and Sarepta Therapeutics (NASDAQ:SRPT) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Image source: Zoe’s Kitchen.

Zoe’s gets a bad review

Shares of Zoe’s Kitchen fell more than 8% after getting a downgrade. Analysts at Baird cut their rating on the restaurant-chain stock from outperform to neutral, and they reduced their price target by 20% to $20 per share. The analysts pointed out that Zoe’s is likely to have to deal with higher ingredient costs for its menu items, and that could put pressure on the company’s earnings when Zoe’s reports its first-quarter results later this week. Tough conditions in the restaurant industry have already weighed on the company, and Zoe’s shares are at their worst levels in its short history as a public company. Without a quick turnaround, it could be difficult for Zoe’s Kitchen to regain investors’ confidence going forward.

Top 10 Stocks For 2019: Atara Biotherapeutics, Inc.(ATRA)

Advisors’ Opinion:

  • [By Danny Vena, George Budwell, and Daniel Miller]

    With that in mind, we asked three Motley Fool contributors to identify growth stocks with intriguing potential that might not be on the radar of most investors. They pickedShopify Inc. (NYSE:SHOP), Atara Biotherapeutics, Inc. (NASDAQ:ATRA), and Criteo S.A. (NASDAQ:CRTO).

  • [By Joseph Griffin]

    Atara Biotherapeutics (NASDAQ:ATRA) had its price target decreased by Citigroup from $25.00 to $23.00 in a report released on Monday. Citigroup currently has a sell rating on the biotechnology company’s stock.

  • [By Chris Lange]

    Atara Biotherapeutics Inc. (NASDAQ: ATRA) shares surged on Friday after the firm announced that it received clearance from the U.S. Food and Drug Administration (FDA) to initiate two Phase 3 clinical studies. Specifically these mid-stage studies deal with tabelecleucel in patients with rituximab-refractory Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+PTLD).

  • [By Joseph Griffin]

    Atara Biotherapeutics (NASDAQ:ATRA) Director Matthew K. Fust sold 12,286 shares of Atara Biotherapeutics stock in a transaction dated Monday, May 14th. The stock was sold at an average price of $43.57, for a total value of $535,301.02. Following the completion of the transaction, the director now directly owns 19,820 shares of the company’s stock, valued at approximately $863,557.40. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

  • [By George Budwell]

    With this theme in mind, I think investors shouldn’t shy away from buying shares of either Atara Biotherapeutics (NASDAQ:ATRA) or CRISPR Therapeutics (NASDAQ:CRSP)right now — even though both of these biotech stocks are currently trading close to their all-time highs. Here’s why.

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    In order to help you get started, we asked three real-world investors who also write for The Motley Fool to put forth their best “buy now” growth stock ideas, and they came up with high-growth home builderLGI Homes Inc(NASDAQ:LGIH),return-to-growth restaurant chainChipotle Mexican Grill, Inc.(NYSE:CMG), and upstart immunotherapy developerAtara BioTherapeutics Inc(NASDAQ:ATRA).

Top 10 Stocks For 2019: Orchid Island Capital, Inc.(ORC)

Advisors’ Opinion:

  • [By Paul Ausick]

    Orchid Island Capital Inc. (NYSE: ORC) fell about 9.7% to post a new 52-week low of $7.85 Thursday after closing at $8.69 on Wednesday. The 52-week high is $12.60. Volume of about 5.2 million was nearly 5 times the daily average of around 1.1 million. The company lowered its monthly dividend by 3 cents last night.

Top 10 Stocks For 2019: Qualstar Corporation(QBAK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media headlines about Qualstar (NASDAQ:QBAK) have trended somewhat positive this week, according to Accern. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Qualstar earned a coverage optimism score of 0.10 on Accern’s scale. Accern also assigned news headlines about the electronics maker an impact score of 45.8526636437463 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 10 Stocks For 2019: Xenia Hotels & Resorts, Inc.(XHR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Xenia Hotels & Resorts (NYSE:XHR) – Jefferies Group issued their Q2 2018 earnings per share (EPS) estimates for Xenia Hotels & Resorts in a note issued to investors on Thursday, May 31st. Jefferies Group analyst D. Katz forecasts that the real estate investment trust will post earnings per share of $0.62 for the quarter. Jefferies Group has a “Buy” rating and a $29.00 price objective on the stock. Jefferies Group also issued estimates for Xenia Hotels & Resorts’ Q3 2018 earnings at $0.48 EPS, Q4 2018 earnings at $0.46 EPS and FY2018 earnings at $2.06 EPS.

  • [By Shane Hupp]

    LSV Asset Management lifted its stake in Xenia Hotels & Resorts (NYSE:XHR) by 18.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,446,848 shares of the real estate investment trust’s stock after acquiring an additional 679,100 shares during the quarter. LSV Asset Management owned approximately 4.16% of Xenia Hotels & Resorts worth $87,691,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Xenia Hotels & Resorts (XHR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks For 2019: Merit Medical Systems Inc.(MMSI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Merit Medical Systems, Inc. (NASDAQ:MMSI) has been assigned a consensus recommendation of “Buy” from the fourteen brokerages that are presently covering the company, Marketbeat.com reports. Thirteen research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $52.00.

  • [By Max Byerly]

    Eagle Boston Investment Management Inc. increased its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 412,344 shares of the medical instruments supplier’s stock after buying an additional 20,334 shares during the quarter. Merit Medical Systems comprises approximately 1.9% of Eagle Boston Investment Management Inc.’s holdings, making the stock its 4th largest position. Eagle Boston Investment Management Inc. owned 0.82% of Merit Medical Systems worth $18,699,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

Top 10 Stocks For 2019: Amtech Systems Inc.(ASYS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Stephan Byrd]

    ValuEngine cut shares of Amtech Systems (NASDAQ:ASYS) from a hold rating to a sell rating in a research note published on Wednesday morning.

    Separately, Zacks Investment Research raised Amtech Systems from a sell rating to a hold rating in a research report on Monday, April 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of $14.88.

  • [By Stephan Byrd]

    Brooks Automation (NASDAQ: BRKS) and Amtech Systems (NASDAQ:ASYS) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

Top 10 Stocks For 2019: Royal Gold Inc.(RGLD)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    Although gold streaming is something of a niche in the precious metals market, the largest competitors have been in the business since the 1980s,while new entrants are showing up as well (including hedge funds, private equity, and pension funds). Most investors, however, should probably stick with the largest, easiest to trade, and longest-tenured companies for now. Here are the top five.

    Company Market Cap Dividend Yield

    Franco-Nevada (NYSE:FNV) $13 billion 1.3%
    Wheaton Precious Metals (NYSE:WPM) $9 billion 1.7%
    Royal Gold (NASDAQ:RGLD) $6 billion 1.2%
    Osisko Gold Royalties Ltd. $1.6 billion 1.6%
    Sandstorm Gold Ltd. $800 million N/A

    Franco-Nevada

    The largest streaming company by market cap is Franco-Nevada. As noted above, it has investments in nearly 300 mines, 50 of which are producing. However, it has taken diversification further than its peers by investing in around 80 oil and natural gas assets (57 producing), following the same basic business model. It’s not as pure a play on metals, but if you are looking for diversification, that non-precious-metals exposure is an interesting addition to the mix. That said, gold provides roughly 70% of its revenue, with silver at 15%, and oil and gas at just 7% (the rest is, effectively, “other”), meaning that gold is still the big driver of performance here. The company has increased its dividend annually for 10 consecutive years.

  • [By Reuben Gregg Brewer]

    This, however, is where streaming company Wheaton Precious Metals (NYSE:WPM)and its peers Royal Gold (NASDAQ:RGLD) and Franco-Nevada (NYSE:FNV)come into play. Streaming companies provide cash up front to miners for the right to buy gold and silver in the future at reduced rates. Often miners use the money to build new mines. Wheaton provided $625 million in cash to Barrick for the development of Pascua-Lama. That is just one of 10 development projects in which Wheaton has invested. Its portfolio also contains 17 operating mines.

  • [By Maxx Chatsko]

    That’s not exactly great historical company. That also explains why gold fever is spreading among investors again, as it inevitably does when economic conversations turn gloomy. I think it’s better to buy and hold stocks for the long haul, but for those considering buying gold directly, I’d encourage a different strategy. That is, buying the best gold stock instead: streaming company Royal Gold (NASDAQ:RGLD).

  • [By Reuben Gregg Brewer]

    Precious metals streaming and royalty company Royal Gold, Inc. (NASDAQ:RGLD) used the commodity downturn to materially increase its production of gold and silver. The increased production, coupled with improving gold prices, led to a massive 56% increase in cash flow between fiscal 2016 and 2017. But higher gold prices have changed the opportunity set and led Royal Gold to focus on preparing for a new growth phase.

  • [By Reuben Gregg Brewer]

    Gold streaming company Franco-Nevada Corporation (NYSE:FNV) offers investors a unique way to gain exposure to precious metals, but when you compare it to peers Royal Gold, Inc. (NASDAQ:RGLD) and Wheaton Precious Metals Corp. (NYSE:WPM)it looks relatively expensive. That said, if you are looking to gold for diversification you might still find that Franco-Nevada Corporation stock is a buy.

  • [By Joseph Griffin]

    Royal Gold, Inc (NASDAQ:RGLD) (TSE:RGL) announced a quarterly dividend on Wednesday, May 30th, RTT News reports. Investors of record on Friday, July 6th will be paid a dividend of 0.25 per share by the basic materials company on Friday, July 20th. This represents a $1.00 annualized dividend and a yield of 1.11%.

Top 10 Stocks For 2019: Devon Energy Corporation(DVN)

Advisors’ Opinion:

  • [By ]

    As things stand right now, analysts anticipate that at least some Iranian oil will come off the market as a result of the sanctions. That lost output would further tighten an oil market that suddenly has little margin for error thanks to red-hot demand and tame supply growth. That’s the recipe for higher oil prices and could make top-tier U.S. oil stocks Anadarko Petroleum (NYSE:APC), Devon Energy (NYSE:DVN), and ConocoPhillips (NYSE:COP) big winners in the coming years.

  • [By Matthew DiLallo]

    As expected, EOG Resources’ U.S. oil output came in above the midpoint of its forecast and was up 15% year over year. Fueling that high-end result were the many wells EOG completed across its vast shale portfolio. The company completed 70 wells in the Delaware Basin during the quarter, with several producing more than 2,000 barrels of oil equivalent per day (BOE/D) in their first month. While the company didn’t match Devon Energy’s (NYSE:DVN) record-smashing 24,000 BOE/D two-well gusher, its wells were highly productive and generated excellent returns.

  • [By Matthew DiLallo]

    As things stand right now, analysts anticipate that at least some Iranian oil will come off the market as a result of the sanctions. That lost output would further tighten an oil market that suddenly has little margin for error thanks to red-hot demand and tame supply growth. That’s the recipe for higher oil prices and could make top-tier U.S. oil stocks Anadarko Petroleum (NYSE:APC), Devon Energy (NYSE:DVN), and ConocoPhillips (NYSE:COP) big winners in the coming years.

  • [By Stephan Byrd]

    These are some of the news headlines that may have impacted Accern Sentiment’s rankings:

    Get Devon Energy alerts:

    Devon Energy (DVN) Presents At UBS Global Oil and Gas Conference – Slideshow (seekingalpha.com) Devon Energy (DVN) Receives Average Rating of “Buy” from Analysts (americanbankingnews.com) Top 5 Upstream Revenues: Higher Realized Prices Drive Growth (finance.yahoo.com) Comparing Stocks: COP, OXY, DVN, EOG, and APC (finance.yahoo.com) Free Research Report as Devon Energys Quarterly Revenues Advanced 7.29% (finance.yahoo.com)

    NYSE:DVN traded down $1.11 during trading hours on Friday, hitting $40.58. The company had a trading volume of 6,948,699 shares, compared to its average volume of 7,939,727. The stock has a market cap of $21.24 billion, a P/E ratio of 64.41, a price-to-earnings-growth ratio of 4.37 and a beta of 2.16. Devon Energy has a 52 week low of $28.79 and a 52 week high of $45.16. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.70.

Top 10 Stocks For 2019: Illinois Tool Works Inc.(ITW)

Advisors’ Opinion:

  • [By Shane Hupp]

    Clinton Group Inc. boosted its position in shares of Illinois Tool Works Inc. (NYSE:ITW) by 923.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 27,009 shares of the industrial products company’s stock after purchasing an additional 24,370 shares during the quarter. Clinton Group Inc.’s holdings in Illinois Tool Works were worth $3,742,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Peapack Gladstone Financial Corp reduced its stake in Illinois Tool Works (NYSE:ITW) by 7.3% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 19,575 shares of the industrial products company’s stock after selling 1,536 shares during the quarter. Peapack Gladstone Financial Corp’s holdings in Illinois Tool Works were worth $3,067,000 at the end of the most recent reporting period.

  • [By ]

    Cramer and the AAP team are trimming Illinois Tool Works (ITW) and Danaher (DHR) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Top 10 Stocks For 2019: SandRidge Mississippian Trust II(SDR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Matador Resources (NYSE: MTDR) and SandRidge Mississippian Trust II (NYSE:SDR) are both oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability.

Best Stocks To Invest In 2018

#lazy-img-327984472:before{padding-top:62.41666666666668%;}

The consensus view sees U.K. inflation trickling back to the Bank of England’s target by the end of 2019. Bloomberg Economics takes a different view: Even accounting for the recent rally in oil prices, it expects the rate to drop faster this year as companies complete the process of passing on higher import costs to consumers. With domestic costs assumed to build slowly, inflation should drop below the BOE goal next year, before returning to 2 percent in 2020.

LISTEN TO ARTICLE :30

Best Stocks To Invest In 2018: ONEOK Inc.(OKE)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    For an example of just how important this is, take a look at the graph below. Midstream companies ONEOK Inc. (NYSE:OKE), Magellan Midstream Partners LP(NYSE:MMP), and Enterprise Products Partners L.P. (NYSE:EPD) have each increased their disbursements for more than a decade. However, there is a difference in the growth rates over time. Enterprise’s 10-year annualized distribution increase was 5.7%, Magellan’s was 10.9%, and ONEOK’s dividend rose at an annualized 16.1% clip. Just a few percentage points here makes a huge difference in the growth of the disbursement over time, as the chart below clearly shows.

  • [By Reuben Gregg Brewer]

    Kinder Morgan, Inc. (NYSE:KMI) is one of the largest midstream companies in North America, and it has major dividend plans between 2018 and 2020. By the end of that period, it expects to increase its dividend from $0.50 per share per year (in 2017) to $1.25. That’s huge dividend growth in a short period of time. But don’t get too enamored by that news; the dividend will still be lower than it was before the midstream oil and gas company’s 75% dividend cut in 2016. If you’re looking for dividend income in the midstream space, take a look at longtime dividend payers ONEOK, Inc. (NYSE:OKE) and Magellan Midstream Partners, L.P. (NYSE:MMP) instead.

  • [By Max Byerly]

    Prudential Financial Inc. boosted its stake in ONEOK (NYSE:OKE) by 1.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 535,375 shares of the utilities provider’s stock after acquiring an additional 5,560 shares during the period. Prudential Financial Inc.’s holdings in ONEOK were worth $30,474,000 at the end of the most recent reporting period.

  • [By Matthew DiLallo]

    ONEOK (NYSE:OKE) is off to a fast start in 2018. The pipeline and processing giant has benefited from the improvement in the oil market because drillers are completing more wells, which are flowing into its system. However, as good as the first quarter was, it’s only the beginning for investors, which management made clear on the accompanying conference call with the following points:

Best Stocks To Invest In 2018: EnLink Midstream Partners, LP(ENLK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ValuEngine upgraded shares of EnLink Midstream Partners (NYSE:ENLK) from a strong sell rating to a sell rating in a research report released on Thursday morning.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on EnLink Midstream Partners (ENLK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    The company took a major step in that direction this week after announcing that it had agreed to sell its stakes in midstream companies EnLink Midstream Partners (NYSE:ENLK) and EnLink Midstream (NYSE:ENLC) for $3.125 billion in cash. The shale driller plans to use that cash to repurchase up to $4 billion of its shares through the end of next year, assuming this transaction closes. These moves could unlock significant shareholder value in the coming year.

  • [By Stephan Byrd]

    Enable Midstream Partners (NYSE: ENBL) and EnLink Midstream Partners (NYSE:ENLK) are both mid-cap oils/energy companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.

Best Stocks To Invest In 2018: Ollie's Bargain Outlet Holdings, Inc.(OLLI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Ollie’s Bargain Outlet (NASDAQ:OLLI) had its price target hoisted by stock analysts at Credit Suisse Group from $68.00 to $78.00 in a research report issued on Wednesday, The Fly reports. The firm currently has an “outperform” rating on the stock. Credit Suisse Group’s price objective would indicate a potential upside of 3.59% from the stock’s previous close.

  • [By Joseph Griffin]

    Tuesday Morning (NASDAQ: TUES) and Ollie’s Bargain Outlet (NASDAQ:OLLI) are both retail/wholesale companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends.

  • [By Max Byerly]

    Ollie’s Bargain Outlet (NASDAQ:OLLI) had its price objective increased by JPMorgan Chase & Co. from $70.00 to $84.00 in a report released on Tuesday morning. They currently have an overweight rating on the stock.

  • [By Motley Fool Staff]

    Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ:OLLI)Q1 2018 Earnings Conference CallJune 5, 2018, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Swiss National Bank lifted its position in Ollie’s Bargain Outlet (NASDAQ:OLLI) by 0.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 85,200 shares of the company’s stock after acquiring an additional 800 shares during the period. Swiss National Bank owned about 0.14% of Ollie’s Bargain Outlet worth $5,138,000 as of its most recent SEC filing.

Best Stocks To Invest In 2018: DXP Enterprises Inc.(DXPE)

Advisors’ Opinion:

  • [By Logan Wallace]

    American Century Companies Inc. decreased its position in DXP Enterprises, Inc. (NASDAQ:DXPE) by 63.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 266,785 shares of the industrial products company’s stock after selling 454,667 shares during the quarter. American Century Companies Inc. owned approximately 1.54% of DXP Enterprises worth $10,391,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on DXP Enterprises (DXPE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Stocks To Invest In 2018: Merit Medical Systems Inc.(MMSI)

Advisors’ Opinion:

  • [By Max Byerly]

    Eagle Boston Investment Management Inc. increased its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 412,344 shares of the medical instruments supplier’s stock after buying an additional 20,334 shares during the quarter. Merit Medical Systems comprises approximately 1.9% of Eagle Boston Investment Management Inc.’s holdings, making the stock its 4th largest position. Eagle Boston Investment Management Inc. owned 0.82% of Merit Medical Systems worth $18,699,000 at the end of the most recent reporting period.

  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Stocks To Invest In 2018: Dover Corporation(DOV)

Advisors’ Opinion:

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Dover Corp. (NYSE: DOV) which traded down about 18% at $76.68. The stocks 52-week range is $75.88 to $109.06. Volume was 3.7 million compared to the daily average volume of 1.6 million.

  • [By Joseph Griffin]

    Dover (NYSE:DOV) had its price target decreased by Stifel Nicolaus from $104.00 to $85.00 in a report published on Thursday. Stifel Nicolaus currently has a hold rating on the industrial products company’s stock.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Dover Corp. (NYSE: DOV) which rose about 4% to $103.82. The stocks 52-week range is $76.23 to $109.06. Volume was 4.7 million compared to the daily average volume of 1.1 million.

Top 10 Performing Stocks To Watch For 2018

9 New 2018 Tax Numbers to Know

Stan the Annuity Man Is Livid About Fixed Indexed Annuities

The Ear of the Beholder: Words Clients Hate, Words Clients Like

Schwab Intelligent Portfolios was the top performing robo-advisor for the third quarter, according to BackEndBenchmarking’s latest Robo Report, which tracks the performance of a 60/40 stock/bond portfolio for investors in a high tax bracket.

Its model portfolio for taxable accounts outperformed comparable portfolios of 19 other robos, gaining 3.97% in the third quarter, according to The Robo Report, which actually invests in the model portfolios it analyzes.

(Related: Which Robo-Advisors Are Best? To Find Out, an RIA Invests in Them)

Betterment placed second for the third quarter followed by SigFig and SoFi, which tied for third place, but it led the competition for one-year performance ended Sept. 30, up 11.97%. Schwab was just behind, with an 11.93% return for its model portfolio.

Top 10 Performing Stocks To Watch For 2018: International Tower Hill Mines Ltd(THM)

Advisors’ Opinion:

  • [By Money Morning News Team]

    While a 209% gain is exciting, FunctionX’s gains are in the past. After looking at the 10 top penny stocks to watch this week, we’ll show you a small-cap stock with serious profit potential ahead of it…

    Penny Stock Current Share Price Law Week’s Gain
    FunctionX Inc. (OTCMKTS: FNCX) $0.03 209%
    Turtle Beach Corp. (Nasdaq: HEAR) $4.48 52.73%
    DPW Holdings Inc. (NYSE: DPW) $1.16 51.31%
    Energy XXI Gulf Coast Inc. (Nasdaq: EGC) $5.62 49.33%
    MYnd Analytics Inc. (Nasdaq: MYND) $1.91 49.21%
    Kingtone Wirelessinfo Solutions Holding Ltd. (Nasdaq: KONE) $6.43 48.42%
    Rennova Health Inc. (OTCMKTS: RNVA) $0.02 44.30%
    International Tower Hill Mines Ltd. (NYSE: THM) $0.72 41.64%
    Blonder Tongue Labs Inc. (NYSE: BDR) $1.13 41.14%
    Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM) $8.87 40.53%

    As the gains above suggest, penny stocks can provides tremendous returns for investors very quickly. However, it’s important to note that investing in penny stocks is also inherently risky.

Top 10 Performing Stocks To Watch For 2018: Container Store (The)(TCS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Container Store Group Inc (NYSE: TCS) is expected to post its quarterly earnings at $0.21 per share on revenue of $230.53 million.

    J & J Snack Foods Corp (NASDAQ: JJSF) is estimated to post its quarterly earnings at $0.78 per share on revenue of $231.58 million.

  • [By Lisa Levin]

    Container Store Group Inc (NYSE: TCS) shares shot up 27 percent to $5.29 after the company posted upbeat results for its fourth quarter and issued a strong forecast for FY 2017.

Top 10 Performing Stocks To Watch For 2018: Cumberland Pharmaceuticals Inc.(CPIX)

Advisors’ Opinion:

Top 10 Performing Stocks To Watch For 2018: Graham Corporation(GHM)

Advisors’ Opinion:

  • [By Monica Gerson]

    Graham Corporation (NYSE: GHM) is expected to report its quarterly earnings at $0.12 per share on revenue of $23.54 million.

    Heico Corp (NYSE: HEI) is estimated to post its quarterly earnings at $0.54 per share.

Top 10 Performing Stocks To Watch For 2018: Siebert Financial Corp.(SIEB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Siebert Financial Corp. (NASDAQ: SIEB) shares shot up 61 percent to $8.30 following news it will offer deeply discounted online trading of U.S. equities next year.

  • [By Cameron Saucier]

    Siebert (Nasdaq: SIEB) is a holding company that has a retail discount brokerage business through its subsidiary, Muriel Siebert & Co. SIEB rose 60% last month after it announced a purchasing agreement with Kennedy Cabot Acquisition. Under the agreement, Kennedy Cabot will purchase shares of SIEB. SIEB is currently trading at $3.37 per share and is up 157% YOY.

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggested shorting small cap discount brokerageSiebert Financial Corp (NASDAQ: SIEB):

    Siebert Financial has been on our watchlist for a while, overbought and toying with the idea of a pullback. We’re finally starting to see evidence that the weight of the gain is taking a toll. We’ve seen a string of lower highs following the last bullish gasp from the 9th. We’re going to assume that was the pivot point. (It has been so far, anyway.)

  • [By Garrett Baldwin]

    William may be right about a sell-off in stocks… in the cryptocurrency space. Over the last week, companies that have billed themselves as blockchain-focused saw their stocks surge. One firm – Long Island Iced Tea changed its name to Long Island Blockchain and watched its stock surge more than triple digits. But today, firms with this exposure are cratering. MGT Capital Investments Inc. (OTCMKTS: MGTI), Long Island Iced Tea Corp. (Nasdaq: LTEA), Riot Blockchain Inc. (Nasdaq: RIOT), and Siebert Financial Corp. (Nasdaq: SIEB) all fell by more than 12% Friday.

Top 10 Performing Stocks To Watch For 2018: Steelcase Inc.(SCS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Steelcase Inc. (NYSE: SCS) shares dropped 14 percent to $14.10 after the company reported downbeat earnings for its first quarter and issued a weak outlook for the second quarter.

  • [By Stephen Mack]

    Jim Hackett spent two decades as CEO of Michigan-based office furniture company Steelcase Inc. (NYSE: SCS). When he took over, the American workplace was shifting away from cubicles, and the company looked on the verge of extinction, with $70 million in annual losses.

  • [By Lisa Levin]

    Steelcase Inc. (NYSE: SCS) shares shot up 5 percent to $15 as the company reported better-than-expected results for its second quarter.

    Shares of Nabriva Therapeutics plc (NASDAQ: NBRV) got a boost, shooting up 10 percent to $9.71. Nabriva Therapeutics announced a $80 million common stock offering.

Top 10 Performing Stocks To Watch For 2018: Cincinnati Financial Corporation(CINF)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Cincinnati Financial (CINF) tumbled to the bottom of the S&P 500 today after the insurer warned of larger catastrophe losses and lower reserve releases.

    Getty Images

    Cincinnati Financialdropped 6.7% to $69.91 today, while the S&P 500 declined 0.2% to 2,270.44.

    Sandler O’Neil’s Paul Newsome and team explain why Cincinnati Financial got hammered today:

    On January 12, 2017, before the market opened, CINF pre-announced 4Q16 catastrophe loss estimates and underwriting results. The company expects 4Q16 earnings to include pre-tax catastrophe losses of approximately $75 million to $85 million, representing an impact on the combined ratio of approximately 6.5 to 7.5 percentage points, based on estimated property casualty earned premiums…

    While the press release headline led with higher catastrophe losses, the real issue was less favorable reserve development related to the companys commercial casualty line.Cincinnati Financial has been growing faster than its peers for some time. The company has been growing primarily due to geographic expansion which is better than growth through price cutting. Nevertheless, growth during a soft market is difficult and the fourth quarter profit warning will likely lead to renewed concerns thatCincinnati Financial cannot maintain its excellent profitability in its commercial insurance business.

    Cincinnati Financial’s market capitalization fell to $11.5 billion today from $12.3 billion yesterday. It reported net income of $634 million on sales of $5.2 billion in 2015.

Top 10 Performing Stocks To Watch For 2018: Merit Medical Systems Inc.(MMSI)

Advisors’ Opinion:

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston

Top 10 Performing Stocks To Watch For 2018: Platinum Group Metals Ltd.(PLG)

Advisors’ Opinion:

  • [By William Patalon III]

    Our sub-$2 “Gold Market Anomaly” play – Platinum Group Metals Ltd. (NYSE: PLG) – took a hit of more than 12% Wednesday after the miner raised $20 million through a stock offering.

Top 10 Performing Stocks To Watch For 2018: Natus Medical Incorporated(BABY)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Elite Opportunity Pronewsletter suggested going long on small cap healthcare products and services stock Natus Medical (NASDAQ: BABY):

Best Warren Buffett Stocks To Buy Right Now

Earnings Reporter

My goal in this segment is to unlock both short-term and long-term growth in stocks that have just reported earnings. These stocks are specifically subject to enormous volatility, as earnings reports are seen (and rightfully so) as a significant display of a company’s progression in the market. What I offer you is an analysis of the economic well-being of the company, and whether I think the stock is a buy, hold or sell for either (or both) the short term or long term. To get used to the format of this segment, take a look at my last article on Tile Shop Holdings (NASDAQ:TTS).

After careful consideration, I have rated Air Lease Corp. (NYSE:AL) as a buy for the short term.

Air Lease Q4 Earnings

The airline industry has been doing extraordinarily well as of late, and investors have surely taken notice of Warren Buffett’s increase investment in the industry. Aircraft manufacturing companies like Boeing (NYSE:BA) are doing well, as well as airline companies such as like Delta Air Lines (NYSE:DAL) and United (NYSE:UAL). In this thriving industry, Air Lease is a company that will surely benefit and prosper. It is essentially the “middle man” in this industry, buying directly from Boeing, and then leasing aircraft to multiple airlines. Let’s take a look at Air Lease Corp.’s Q4 to get insight into how the company is faring in today’s economy.

Best Warren Buffett Stocks To Buy Right Now: International Business Machines Corporation(IBM)

Advisors’ Opinion:

  • [By ]

    Last but not least, the conversion and consolidation of the American healthcare colossus will be a bonanza for tech companies engaged in networking, software, and the cloud. Those best suited to handle the task are the usual suspects: Cisco Systems (Nasdaq: CSCO), Microsoft (Nasdaq: MSFT), IBM (NYSE: IBM), CA Technologies (Nasdaq: CA), Oracle (Nasdaq: ORCL), and Hewlett Packard (NYSE: HPE).

  • [By Chris Lange]

    So how does International Business Machines Corp. (NYSE: IBM) compare to the markets over the past nine years?

    On an adjusted close basis, IBM closed March 6, 2009, at $68.36 a share, or $85.81 on an unadjusted basis. IBM most recently closed at $155.83 on an adjusted basis.

  • [By Danny Vena]

    H&R Block, Inc. (NYSE:HRB) is hoping to change all that. This year, it’s partnering with IBM’s (NYSE:IBM) Watson to bring the capabilities of artificial intelligence (AI) to tax return preparation. This would seem a natural fit for theJeopardy!-winning supercomputer.

  • [By WWW.MONEYSHOW.COM]

    We reprise five of last year’s components: Boeing (BA), CVS Health (CVS), International Business Machines (IBM), Omnicom Group (OMC) and Texas Instruments (TXN), which means they obviously are buys.

  • [By WWW.USATODAY.COM]

    In the year 2000, IBM’s (NYSE: IBM) most notable cash cow was the computer server the software giant sold nearly $11.5 billion worth of them that year.Today, servers still figure in IBM’s product mix, but their sales have dwindled by more than 70% in the 21stcentury, making up just 4% of IBM’s total revenue last year.

Best Warren Buffett Stocks To Buy Right Now: Bank of Nova Scotia (The)(BNS)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Bank of Nova Scotia (The) (NYSE: BNS): Free Stock Analysis Report
     
    Banco Bilbao Viscaya Argentaria S.A. (NYSE: BBVA): Free Stock Analysis Report
     
    Credicorp Ltd. (NYSE: BAP): Free Stock Analysis Report
     
    Bank of N.T. Butterfield & Son Limited (The) (NTB): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.

Best Warren Buffett Stocks To Buy Right Now: Snap-On Incorporated(SNA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Coming up on this episode of Mad Money: Cramer interviews Nick Pinchuk, CEO of Snap-on (SNA) . Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

  • [By John Divine]

    Snap-on Incorporated (SNA) is my choice for the Best Stocks for 2016 competition. At a market cap of $10 billion, I doubt it will double over the next year, as some of the smaller companies in this competition might be able to.

    That said, Snap-on, which manufactures and markets hand tools and diagnostic equipment, is a rock-solid company with an attractive valuation and impressive growth. It goes for 22 times earnings, pays a consistent and modest dividend, and has been around since 1920.

    As cars get more tech-heavy and complicated, newer tools and better diagnostics will be needed — and that’s SNA’s bread ‘n’ butter. 

  • [By WWW.MONEYSHOW.COM]

    Snap-on (SNA)

    Snap-on, which is more than 100 years old, provides hand and power tools for individuals and professionals, including auto-shop tools and auto diagnostic equipment.

Best Warren Buffett Stocks To Buy Right Now: Merit Medical Systems Inc.(MMSI)

Advisors’ Opinion:

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston

Best Warren Buffett Stocks To Buy Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Best Warren Buffett Stocks To Buy Right Now: Tallgrass Energy Partners, LP(TEP)

Advisors’ Opinion:

  • [By Garrett Cook]

    Citi remains Buy rated on Dominion Midstream Partners (NYSE: DM), Tallgrass Energy (NYSE: TEP), and Tallgrass Energy GP (NYSE: TEGP), saying the companies are positioned to capitalize on natural gas demand growth.